Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
Invesco Solar ETF
TAN
4
The Technology Select Sector SPDR® Fund
XLK
5
iShares US Telecommunications ETF
IYZ
No Data
BioNxt Advances Semaglutide ODF Program Into Active Pharmaceutical Development
BioNxt Solutions Inc: MDA EN
BioNxt Solutions Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
BioNxt Applies Advanced Drug Delivery Strategy and Psychedelic Compound Library to Emerging Therapeutics Market Amid Accelerating Global Momentum
BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)
BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries